Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2020

Mar 3, 2020

29777_dirs_2020-03-03_5fee3e62-e5ff-4d07-8555-6ef671aadf9d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2020-02-28

Reporting Person: MANNING JOSEPH J (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-28 Common shares without par value A 4436 Acquired 68720 Direct
2020-02-28 Common shares without par value F 5909 $79.19 Disposed 62811 Direct

Footnotes

F1: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.